These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 29806773)
1. Selective Substrates and Activity-Based Probes for Imaging of the Human Constitutive 20S Proteasome in Cells and Blood Samples. Rut W; Poręba M; Kasperkiewicz P; Snipas SJ; Drąg M J Med Chem; 2018 Jun; 61(12):5222-5234. PubMed ID: 29806773 [TBL] [Abstract][Full Text] [Related]
3. A panel of subunit-selective activity-based proteasome probes. Verdoes M; Willems LI; van der Linden WA; Duivenvoorden BA; van der Marel GA; Florea BI; Kisselev AF; Overkleeft HS Org Biomol Chem; 2010 Jun; 8(12):2719-27. PubMed ID: 20449511 [TBL] [Abstract][Full Text] [Related]
4. A Peptidomimetic Fluorescent Probe to Detect the Trypsin β2 Subunit of the Human 20S Proteasome. Wysocka M; Romanowska A; Gruba N; Michalska M; Giełdoń A; Lesner A Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244300 [TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibitor-induced apoptosis in acute myeloid leukemia: a correlation with the proteasome status. Matondo M; Bousquet-Dubouch MP; Gallay N; Uttenweiler-Joseph S; Recher C; Payrastre B; Manenti S; Monsarrat B; Burlet-Schiltz O Leuk Res; 2010 Apr; 34(4):498-506. PubMed ID: 19811823 [TBL] [Abstract][Full Text] [Related]
6. 1,2,4-Oxadiazoles identified by virtual screening and their non-covalent inhibition of the human 20S proteasome. Maréchal X; Genin E; Qin L; Sperandio O; Montes M; Basse N; Richy N; Miteva MA; Reboud-Ravaux M; Vidal J; Villoutreix BO Curr Med Chem; 2013; 20(18):2351-62. PubMed ID: 23531222 [TBL] [Abstract][Full Text] [Related]
7. Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates. Kisselev AF; Goldberg AL Methods Enzymol; 2005; 398():364-78. PubMed ID: 16275343 [TBL] [Abstract][Full Text] [Related]
8. Electrochemical assay for 20S proteasome activity and inhibition with anti-cancer drugs. Henriques de Jesus CS; Chiorcea-Paquim AM; Barsan MM; Diculescu VC Talanta; 2019 Jul; 199():32-39. PubMed ID: 30952265 [TBL] [Abstract][Full Text] [Related]
9. Immunoaffinity purification of the functional 20S proteasome from human cells via transient overexpression of specific proteasome subunits. Livinskaya VA; Barlev NA; Nikiforov AA Protein Expr Purif; 2014 May; 97():37-43. PubMed ID: 24583181 [TBL] [Abstract][Full Text] [Related]
10. Human 20S proteasome activity towards fluorogenic peptides of various chain lengths. Rut W; Drag M Biol Chem; 2016 Sep; 397(9):921-6. PubMed ID: 27176742 [TBL] [Abstract][Full Text] [Related]
11. Fluorescent Probes with Unnatural Amino Acids to Monitor Proteasome Activity in Real-Time. Zerfas BL; Coleman RA; Salazar-Chaparro AF; Macatangay NJ; Trader DJ ACS Chem Biol; 2020 Sep; 15(9):2588-2596. PubMed ID: 32786259 [TBL] [Abstract][Full Text] [Related]
12. The capture proteasome assay: A method to measure proteasome activity in vitro. Vigneron N; Abi Habib J; Van den Eynde BJ Anal Biochem; 2015 Aug; 482():7-15. PubMed ID: 25912419 [TBL] [Abstract][Full Text] [Related]
13. A Set of Activity-Based Probes to Visualize Human (Immuno)proteasome Activities. de Bruin G; Xin BT; Kraus M; van der Stelt M; van der Marel GA; Kisselev AF; Driessen C; Florea BI; Overkleeft HS Angew Chem Int Ed Engl; 2016 Mar; 55(13):4199-203. PubMed ID: 26511210 [TBL] [Abstract][Full Text] [Related]
15. Profiling proteasome activity in tissue with fluorescent probes. Berkers CR; van Leeuwen FW; Groothuis TA; Peperzak V; van Tilburg EW; Borst J; Neefjes JJ; Ovaa H Mol Pharm; 2007; 4(5):739-48. PubMed ID: 17708652 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of local anesthetics on the proteasome and their biological actions. Bahrudin U; Unno M; Nishio K; Kita A; Li P; Kato M; Inoue M; Tsujitani S; Murakami T; Sugiyama R; Saeki Y; Obara Y; Tanaka K; Yamaguchi H; Sakane I; Kawata Y; Itoh T; Ninomiya H; Hisatome I; Morimoto Y Sci Rep; 2017 Jul; 7(1):5079. PubMed ID: 28698635 [TBL] [Abstract][Full Text] [Related]
17. Investigation of the P1' and P2' sites of IQF substrates and their selectivity toward 20S proteasome subunits. Gladysz R; Malek N; Rut W; Drag M Biol Chem; 2023 Feb; 404(2-3):221-227. PubMed ID: 36376064 [TBL] [Abstract][Full Text] [Related]
18. A mass spectrometry platform for a streamlined investigation of proteasome integrity, posttranslational modifications, and inhibitor binding. Gersch M; Hackl MW; Dubiella C; Dobrinevski A; Groll M; Sieber SA Chem Biol; 2015 Mar; 22(3):404-11. PubMed ID: 25728267 [TBL] [Abstract][Full Text] [Related]
19. Elucidating the catalytic subunit composition of distinct proteasome subtypes: a crosslinking approach employing bifunctional activity-based probes. Cornish Carmony K; Sharma LK; Lee DM; Park JE; Lee W; Kim KB Chembiochem; 2015 Jan; 16(2):284-92. PubMed ID: 25477005 [TBL] [Abstract][Full Text] [Related]
20. Dimerized linear mimics of a natural cyclopeptide (TMC-95A) are potent noncovalent inhibitors of the eukaryotic 20S proteasome. Desvergne A; Genin E; Maréchal X; Gallastegui N; Dufau L; Richy N; Groll M; Vidal J; Reboud-Ravaux M J Med Chem; 2013 Apr; 56(8):3367-78. PubMed ID: 23540790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]